Intellia Therapeutics Inc buy BMO Capital Markets
Start price
10.05.24
/
50%
€22.72
Target price
10.05.25
€64.98
Performance (%)
-13.25%
Price
31.05.24
€19.71
Summary
This prediction is currently active. The prediction for Intellia Therapeutics Inc disappoints with a performance of -13.25%. This prediction currently runs until 10.05.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Intellia Therapeutics Inc | -13.968% |
iShares Core DAX® | -0.552% |
iShares Nasdaq 100 | -1.415% |
iShares Nikkei 225® | -0.877% |
iShares S&P 500 | -0.415% |
Comments by BMO_Capital_Markets for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target raised by analysts at BMO Capital Markets from $62.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.58
10.11.23
10.11.23
€58.01
10.11.24
10.11.24
-12.71%
31.05.24
31.05.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€36.37
13.03.23
13.03.23
-
13.03.24
13.03.24
-27.88%
14.03.24
14.03.24